Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.

ABSTRACT:

Objectives

In this study, we investigate the effect of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19.

Trial design

The current study is a single-center, randomized, double-blind, placebo-controlled clinical trial with parallel groups.

Participants

The inclusion criteria include male and female patients≥18 years of age, with a confirmed diagnosis of SARS-CoV-2 infection via polymerase chain reaction (PCR) and/or antibody test and with written informed consent to participate in this trial. The exclusion criteria include regular use of any other supplement, severe and critical COVID-19 pneumonia, pregnancy and breastfeeding. This study is being conducted at Imam Reza Hospital, Tabriz University of Medica

SUBMITTER: Tutunchi H 

PROVIDER: S-EPMC7588946 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature